Valacyclovir
신기능 저하

신기능 저하

Herpes labialis

CrCl ≥50

2 g PO q12h

CrCl 30-49

1 g PO q12h

CrCl 10-29

500 mg PO q12h

CrCl <10

500 mg PO q24h

Genital herpes initial episode

CrCl ≥30

1 g PO q12h

CrCl 10-29

1 g PO q24h

CrCl <10

500 mg PO q24h

Genital herpes recurrent episode

CrCl ≥30

500 mg PO q12h

CrCl 10-29

500 mg PO q24h

CrCl <10

500 mg PO q24h

Genital herpes suppression in immunocompetent patients

CrCl ≥30

0.5-1 g PO q24h

CrCl <30

500 mg PO q24-48h

Genital herpes suppression in HIV-infected

CrCl ≥30

500 mg PO q12h

CrCl <30

500 mg PO q24h

Herpes zoster

CrCl ≥50

1 g PO q8h

CrCl 30-49

1 g PO q12h

CrCl 10-29

1 g PO q24h

CrCl <10

500 mg PO q24h